Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Three-year subdermal contraceptive implant marketed in the U.K.

Oct. 25, 1999

Review of Hectorol Injection NDA back on course

Oct. 25, 1999

Orally active DPP-IV inhibitor presented at EASD meeting heads for clinic

Oct. 22, 1999

Approvable letter voices FDA concerns about safety of Ergoset; Ergo Science to study options

Oct. 22, 1999

SB reports temporary setback in European launch of Avandia

Oct. 22, 1999

EASD highlights: novel aldose reductase inhibitor effective in model of diabetic neuropathy

Oct. 21, 1999

Novel prostaglandin analogues useful for bone disorders, glaucoma

Oct. 21, 1999

Ontogen investigates FBPase as novel target for the treatment of hyperglycemia

Oct. 20, 1999

Collaboration on MC-4 receptor agonists signed by Pharmacopeia and Roche

Oct. 19, 1999

Zopolrestat: first report of reversal of preexisting renal hyperperfusion for ARI

Oct. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...